Godrej Agrovet Limited · NSE:GODREJAGRO
Godrej Agrovet — Q1 FY23 Earnings Presentation
22 slides from Godrej Agrovet's earnings presentation, Jul 29, 2022
Slide 1: Presentation to Investors & Analysts cover letter
Date: July 29, 2022 To, To, BSE Limited National Stock Exchange of India Limited P. J. Towers, Dalal Street, Fort Exchange Plaza, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai-400 051 Ref.: BSE Scrip Code No. “540743” Ref.: “GODREJAGRO” Sub: Presentation to Investors & Analysts Dear
Slide 2: Godrej Agrovet Limited Q1 FY23 Performance Update
GODREJ AGROVET LIMITED Q1 FY23 PERFORMANCE UPDATE 1 I Godrej Agrovet
Slide 3: Disclaimer
DISCLAIMER Some of the statements in this communication may be forward looking statements within the meaning of applicable laws and regulations. Actual results might differ substantially from those expressed or implied. Important developments that could affect the Company’s operations include change
Slide 4: ESG Update
ESG UPDATE 3 I Godrej Agrovet
Slide 5: Successful submission of GHG reduction roadmap target in line with SBTi WB2DC scenario
SUCCESSFUL SUBMISSION OF GHG REDUCTION ROADMAP TARGET IN LINE WITH SBTI WB2DC SCENARIO – 1ST AGRI COMPANY IN INDIA ✓ The SBTi is a partnership between CDP, the United Nations Global Compact, World Resources Institute (WRI) and the World Wide Fund for Nature (WWF) ✓ GAVL has committed to reduce absol
Slide 6: Ambitious global commitments & affiliations
AMBITIOUS GLOBAL COMMITMENTS & AFFILIATIONS ▪ Member of the World Business ▪ Member of the Global Agribusiness ▪ Committed to the global Science Council for Sustainable Alliance, of which Mr. Nadir B. Based Targets initiative (SBTi) to Development Godrej is also current chair reduce our emissions in
Slide 7: Our ESG initiatives continued to generate meaningful impact
OUR ESG INITIATIVES CONTINUED TO GENERATE MEANINGFUL IMPACT 75% of the energy GAVL utilizes is from clean renewable energy initiatives ✓ Solar rooftops at 13 manufacturing sites of Animal Feed, Aqua and R&D plants ✓ Our subsidiary, Astec LifeSciences meets 40% of the total energy requirement through
Slide 8: Strong commitment to CSR
STRONG COMMITMENT TO CSR COVID Relief & Recovery Highlights Pragati: Community-based Education ✓ Covid awareness and ✓ 4,706 students engaged in AP & vaccination support to 16,860 Punjab (80% engagement rate) people near 3 factory locations through sports education program ✓ Support for digital educ
Slide 9: Performance Highlights
PERFORMANCE HIGHLIGHTS 8 I Godrej Agrovet
Slide 10: Q1 FY23 Consolidated Financials – Key Highlights
Q1 FY23 CONSOLIDATED FINANCIALS – KEY HIGHLIGHTS Financial Highlights Q1 FY23 Q1 FY22 Growth (Rs. Crore unless Stated) Revenues 2,509.9 1,992.8 25.9% Earnings before interest, tax and Depreciation (EBITDA) 169.3 180.0 -5.9% EBITDA Margin (%) 6.7% 9.0% Profit before Exceptional items, Tax & Share of
Slide 11: Q1 FY23 Segment-wise Revenue and PBIT
Q1 FY23 SEGMENT-WISE REVENUE AND PBIT Segment revenues (1) – Q1 FY23 Segment results (2) – Q1 FY23 Others, 0.9% Poultry & processed food, Animal Feed, Poultry & processed food, Others, 1.0% Animal Feed, 9.3% 46.7% 10.1% 15.0% Dairy, -6.2% Dairy, 14.8% Crop Protection, Crop 27.5% Protection, 13.8% Oi
Slide 12: Segment-wise Performance Update
SEGMENT-WISE PERFORMANCE UPDATE 11 I Godrej Agrovet
Slide 13: Animal Feed
ANIMAL FEED Leading compound feed play across Cattle (Milk), Broiler, Layer, Fish and Shrimp feed in India Particulars Q1 FY23 Q1 FY22 Growth Sales Volume (tons) 3,52,983 3,16,838 11.4% Segment Revenue (Cr) 1,245.9 1,001.3 24.4% Segment Result (Cr) 24.5 63.7 -61.5% Segment Margin (%) 2.0% 6.4% • Rob
Slide 14: Oil Palm Business
OIL PALM BUSINESS Largest domestic producer of Crude Palm oil and Palm Kernel Oil Particulars Q1 FY23 Q1 FY22 Growth Segment Revenue (Cr) 385.2 288.8 33.4% Segment Result (Cr) 85.8 32.6 163.2% Segment Margin (%) 22.3% 11.3% • Solid Q1 FY23 performance driven by higher oil extraction ratio (OER) and
Slide 15: Crop Protection Business
CROP PROTECTION BUSINESS Agrochemical products catering to the entire crop lifecycles Particulars Q1 FY23 Q1 FY22 Growth Segment Revenue (Cr) 198.1 240.5 -17.6% Segment Result (Cr) 26.1 64.0 -59.2% Segment Margin (%) 13.2% 26.6% • Delayed start of south-west monsoon in June led to deferred applicati
Slide 16: Astec LifeSciences
ASTEC LIFESCIENCES Manufactures a wide range of agrochemical active ingredients Particulars Q1 FY23 Q1 FY22 Growth Revenues (Cr) 184.3 128.7 43.3% EBITDA (Cr) 28.2 25.5 10.6% EBITDA Margin (%) 15.3% 19.8% • Higher exports realisations and CMO volumes led to robust topline growth in Q1 FY23. However,
Slide 17: Creamline Dairy
CREAMLINE DAIRY Private dairy player in Southern India with a wide range of product portfolio Particulars Q1 FY23 Q1 FY22 Growth Revenues (Cr) 393.4 266.5 47.6% EBITDA (Cr) (2.4) (3.1) NM EBITDA Margin (%) (0.6%) (1.2%) • Strong volume growth in both value-added products (+69% year-on-year) and milk
Slide 18: Godrej Tyson Foods Limited and ACI Godrej Agrovet joint venture
GODREJ TYSON FOODS LIMITED Particulars Q1 FY23 Q1 FY22 Growth Revenues (Cr) 248.2 177.6 39.8% EBITDA (Cr) 20.9 (0.3) EBITDA Margin (%) 8.4% (0.2%) • Segment reported strong performance in Q1 FY23 led by higher live bird prices and robust volume growth in Real Good Chicken (RGC) category • RGC volume
Slide 19: Annexures
ANNEXURES 18 I Godrej Agrovet
Slide 20: Shareholding Pattern as of June 30, 2022
SHAREHOLDING PATTERN AS OF JUNE 30, 2022 FII Major Investors 10.3% DII ➢ Temasek 7.3% ➢ LIC of India ➢ Nippon Mutual Fund ➢ Vanguard Others 8.7% ➢ Kotak Mutual Fund ➢ DSP ➢ Bajaj Holdings ➢ PGIM India Mutual Fund ➢ LIC Mutual Fund Promoters 73.7% 19 I Godrej Agrovet
Slide 21: Contact Us
CONTACT US To know more, visit us at: www.godrejagrovet.com S Varadaraj Aditya Desai Email: s.varadaraj@godrejagrovet.com Email: aditya.desai@godrejagrovet.com gavlinvestors@godrejagrovet.com gavlinvestors@godrejagrovet.com 20 I Godrej Agrovet
Slide 22: Thank you for your time and consideration
THANK YOU FOR YOUR TIME AND CONSIDERATION 21 I Godrej Agrovet